Sarilumab not checked

Sanofi · SAR153191 · REGN88

FollowEvery change as it happens, and a Monday email
Stage
in the US · approved in the EU
Next date
Phase 2 trial completes
Trials
8 active
15 in total · 7 in the EU
Targets
 

What this is

How it works
Blocks interleukin-6, a signal that drives inflammation.Interleukin-6 Receptor Antagonist FDA class
How it’s given
“Pharmaceutical form: Solution for injection - Route of administration: Subcutaneous”In the company’s words, NCT07286214 on ClinicalTrials.gov
Tested for
Polymyalgia Rheumatica, Juvenile Idiopathic Arthritis, Rheumatoid Arthritis
Main trialPhase 3
“This is a randomized, double-blind, placebo-controlled, parallel-group, Phase 3, 3-arm study to assess whether treatment with sarilumab at either 150 mg q2w (once every two weeks) or at 200 mg q2w, each given with a 52-week prednisone taper, is superior to placebo given with a 52-week prednisone taper in participants with early polymyalgia rheumatica (PMR) and to determine the safety and tolerability of the sarilumab regimens. The study will consist of the following visits: Visit 1 (D-42 to D-1): Screening, Visit 2 (D1): Baseline, randomization, first study drug administration, Visit 3 to…”In the company’s words, NCT07286214 on ClinicalTrials.gov
Other names
Kevzara · SAR153191 · REGN88

Other drugs for Polymyalgia Rheumatica

All 3 drugs for Polymyalgia Rheumatica

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials15

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 4 Jun 2029 Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
Phase 2Recruiting 1 Mar 2028 A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
Phase 1/2Recruiting 26 Oct 2028 Phase 1b/2 Study of IV Sarilumab in Adult With RA
Phase 4Completed 31 Jul 2019 Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis
Phase 3Completed 20 Jan 2016 Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)
Phase 3Completed 31 Jul 2020 Sarilumab COVID-19
Phase 3Terminated 24 Nov 2020 Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA
Phase 3Completed 31 Dec 2020 Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)
Phase 3Terminated 19 May 2021 Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica
Phase 2Completed 8 Apr 2022 An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
Phase 4Authorised not given The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
Phase 4Authorised not given A 24 weeks proof of concept study to evaluate the clinical, MRI and synovial tissue benefit of Sarilumab in active RA patients despite TNF agents
Phase 3/4Authorised not given RANDOMIZED CONTROLLED CLINICAL TRIAL EVALUATING METHOTREXATE OR LEFLUNOMIDE + TARGETED THERAPY VERSUS METHOTREXATE OR LEFLUNOMIDE + SULFASALAZINE + HYDROXYCHLOROQUINE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INSUFFICIENT RESPONSE TO METHOTREXATE OR LEFLUNOMIDE (The BIO-3 trial)
Phase 4Authorised not given Tapering optimisation with placebo-based mechanisms in rheumatoid arthritis: the TOP-RA trial
Phase 4Authorised not given Optimising Arthritis Strategies in Elderly patients (≥70 years) with rheumatoid arthritis in sustained low disease activity (the OASE study): A Prospective Target Trial Emulation Study Evaluating Tapering of Disease-Modifying Anti-Rheumatic Drugs vs. Usual Care Based on Patient Preference
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Sarilumab

Following is part of Solo: you see every change to Sarilumab the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in